Largest health care companies by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Johnson & Johnson leads the 170 health care companies ranked by earnings, at NOK 261.6B, ahead of Eli Lilly (NOK 201.4B) and Merck & Co (NOK 178.1B). Figures as of 19 Nov 2026, 16:24 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 170
- First
- Johnson & JohnsonNOK 261.6B
- Median
- NOK 2.7B
- Combined market value
- NOK 87.2T
- Countries
- 14
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 101 | Hims & Hers HealthHIMS · Health Care | NOK 1.3B | NOK 37.8B | NOK 161.21 | 3.11% down | 49% down | ||
| 102 | Ligand PharmaceuticalsLGND · Health Care | NOK 1.2B | NOK 56.9B | NOK 2,843.91 | 2.44% down | 50% up | ||
| 103 | Corcept TherapeuticsCORT · Health Care | NOK 972.5M | NOK 70.3B | NOK 642.31 | 2.91% down | 10% down | ||
| 104 | HaemoneticsHAE · Health Care | NOK 949.6M | NOK 53.2B | NOK 1,168.83 | 2.52% down | 64% up | ||
| 105 | Amneal PharmaceuticalsAMRX · Health Care | NOK 703.2M | NOK 72.7B | NOK 208.70 | 2.26% down | 90% up | ||
| 106 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | NOK 575.8M | NOK 72.7B | NOK 924.81 | 0.30% down | 129% up | ||
| 107 | RepligenRGEN · Health Care | NOK 477.2M | NOK 109.6B | NOK 1,714.80 | 1.76% up | 12% up | ||
| 108 | LifeStance Health GroupLFST · Health Care | NOK 94.3M | NOK 49.6B | NOK 130.33 | 3.01% down | 123% up | ||
| 109 | BillionToOneBLLN · Health Care | NOK 72.7M | NOK 42.4B | NOK 886.80 | 0.73% down | 4% down | ||
| 110 | Arrowhead PharmaceuticalsARWR · Health Care | -NOK 15.9M | NOK 60B | NOK 424.52 | 0.90% up | 13% up | ||
| 111 | BrukerBRKR · Health Care | -NOK 83.9M | NOK 96B | NOK 628.67 | 1.83% up | 44% up | ||
| 112 | RadNetRDNT · Health Care | -NOK 182M | NOK 53.6B | NOK 680.64 | 2.89% down | 9% down | ||
| 113 | Mirum PharmaceuticalsMIRM · Health Care | -NOK 228M | NOK 60.3B | NOK 923.88 | 2.36% up | 34% up | ||
| 114 | Travere TherapeuticsTVTX · Health Care | -NOK 249.3M | NOK 46.6B | NOK 485.02 | 1.07% down | 45% up | ||
| 115 | 10x GenomicsTXG · Health Care | -NOK 424.9M | NOK 77.8B | NOK 591.74 | 6.25% up | 247% up | ||
| 116 | Adaptive BiotechnologiesADPT · Health Care | -NOK 580.6M | NOK 46B | NOK 284.47 | 2.42% up | 74% up | ||
| 117 | Caris Life SciencesCAI · Health Care | -NOK 664.5M | NOK 54.9B | NOK 191.37 | 0.56% up | 19% down | ||
| 118 | VeradermicsMANE · Health Care | -NOK 683.1M | NOK 51.1B | NOK 1,211.87 | 0.54% down | 231% up | ||
| 119 | Belite BioBLTE · Health Care | -NOK 757.4M | NOK 60.6B | NOK 1,491.76 | 2.16% down | 43% up | ||
| 120 | Twist BioscienceTWST · Health Care | -NOK 758M | NOK 80.5B | NOK 1,180.15 | 3.94% up | 346% up | ||
| 121 | Oruka TherapeuticsORKA · Health Care | -NOK 1B | NOK 65.1B | NOK 959.99 | 2.75% up | 255% up | ||
| 122 | HeartflowHTFL · Health Care | -NOK 1.1B | NOK 39.2B | NOK 446.47 | 0.31% down | 66% up | ||
| 123 | ErascaERAS · Health Care | -NOK 1.2B | NOK 48.4B | NOK 137.99 | 2.76% up | 395% up | ||
| 124 | Protagonist TherapeuticsPTGX · Health Care | -NOK 1.3B | NOK 80.6B | NOK 1,234.46 | 0.52% down | 51% up | ||
| 125 | Charles River Laboratories InternationalCRL · Health Care | -NOK 1.4B | NOK 157.4B | NOK 3,285.16 | 1.01% up | 106% up | ||
| 126 | Spyre TherapeuticsSYRE · Health Care | -NOK 1.5B | NOK 91.8B | NOK 966.77 | 2.36% down | 332% up | ||
| 127 | CG OncologyCGON · Health Care | -NOK 1.6B | NOK 71.7B | NOK 803.16 | 2.87% up | 97% up | ||
| 128 | Dianthus TherapeuticsDNTH · Health Care | -NOK 1.6B | NOK 47B | NOK 834.44 | 1.82% up | 108% up | ||
| 129 | Edgewise TherapeuticsEWTX · Health Care | -NOK 1.6B | NOK 43.9B | NOK 400.80 | 0.73% down | 86% up | ||
| 130 | Axsome TherapeuticsAXSM · Health Care | -NOK 1.8B | NOK 68.9B | NOK 1,310.24 | 0.19% up | 6% down | ||
| 131 | Definium TherapeuticsDFTX · Health Care | -NOK 1.8B | NOK 38.5B | NOK 280.96 | 1.13% down | 168% up | ||
| 132 | GlaukosGKOS · Health Care | -NOK 1.8B | NOK 136B | NOK 2,297.70 | 1.01% up | 145% up | ||
| 133 | Rhythm PharmaceuticalsRYTM · Health Care | -NOK 1.9B | NOK 78.9B | NOK 1,138.68 | 1.98% down | 18% up | ||
| 134 | NateraNTRA · Health Care | -NOK 2B | NOK 424.5B | NOK 2,927.69 | 3.63% up | 28% up | ||
| 135 | Kodiak SciencesKOD · Health Care | -NOK 2.2B | NOK 62.5B | NOK 956.23 | 0.18% up | 399% up | ||
| 136 | Elanco Animal HealthELAN · Health Care | -NOK 2.3B | NOK 129.3B | NOK 258.66 | 0.73% down | 26% up | ||
| 137 | LivaNovaLIVN · Health Care | -NOK 2.4B | NOK 49.8B | NOK 903.49 | 2.07% down | 77% up | ||
| 138 | Ascendis PharmaASND · Health Care | -NOK 2.5B | NOK 169.8B | NOK 2,588.86 | 1.87% down | 29% up | ||
| 139 | Madrigal PharmaceuticalsMDGL · Health Care | -NOK 2.8B | NOK 91.5B | NOK 3,940.96 | 1.44% up | 27% down | ||
| 140 | Legend BiotechLEGN · Health Care | -NOK 2.9B | NOK 30.7B | NOK 158.24 | 0.22% down | 41% down | ||
| 141 | Roivant SciencesROIV · Health Care | -NOK 2.9B | NOK 278.7B | NOK 384.70 | 1.78% up | 91% up | ||
| 142 | Praxis Precision MedicinesPRAX · Health Care | -NOK 3B | NOK 87B | NOK 3,112.43 | 4.50% up | 86% up | ||
| 143 | Kymera TherapeuticsKYMR · Health Care | -NOK 3B | NOK 99.1B | NOK 1,160.83 | 1.80% down | 87% up | ||
| 144 | Cogent BiosciencesCOGT · Health Care | -NOK 3.2B | NOK 47.7B | NOK 274.03 | 0.97% up | 20% down | ||
| 145 | MiniMed GroupMMED · Health Care | -NOK 3.2B | NOK 44.7B | NOK 158.92 | 4.15% down | 8% down | ||
| 146 | ImmunityBioIBRX · Health Care | -NOK 3.4B | NOK 68.5B | NOK 64.36 | 1.57% down | 232% up | ||
| 147 | Jazz PharmaceuticalsJAZZ · Health Care | -NOK 3.5B | NOK 151.2B | NOK 2,355.11 | 2.60% down | 41% up | ||
| 148 | Bausch + LombBLCO · Health Care | -NOK 3.5B | NOK 72.7B | NOK 203.23 | 0.60% down | 44% up | ||
| 149 | ABIVAXABVX · Health Care | -NOK 3.6B | NOK 71.8B | NOK 820.73 | 0.32% up | 32% down | ||
| 150 | Scholar Rock HoldingSRRK · Health Care | -NOK 3.7B | NOK 59.4B | NOK 486.92 | 3.95% up | 26% up | ||
| 151 | Ionis PharmaceuticalsIONS · Health Care | -NOK 3.7B | NOK 43.9B | NOK 263.64 | 1.37% down | 63% down | ||
| 152 | GRAILGRAL · Health Care | -NOK 4B | NOK 47.8B | NOK 1,063.73 | 6.76% up | 19% up | ||
| 153 | Guardant HealthGH · Health Care | -NOK 4.1B | NOK 199.3B | NOK 1,473.51 | 4.03% up | 45% up | ||
| 154 | Oscar HealthOSCR · Health Care | -NOK 4.3B | NOK 81.8B | NOK 263.20 | 2.18% down | 112% up | ||
| 155 | ImmunovantIMVT · Health Care | -NOK 4.9B | NOK 66.7B | NOK 322.34 | 0.42% down | 46% up | ||
| 156 | AvantorAVTR · Health Care | -NOK 5.2B | NOK 101B | NOK 149.12 | 0.58% down | 40% up | ||
| 157 | CRISPR TherapeuticsCRSP · Health Care | -NOK 5.7B | NOK 38.3B | NOK 395.14 | 0.75% up | 18% down | ||
| 158 | BridgeBio PharmaBBIO · Health Care | -NOK 7.2B | NOK 148.6B | NOK 762.66 | 0.18% up | 21% up | ||
| 159 | VaxcytePCVX · Health Care | -NOK 7.5B | NOK 91.8B | NOK 580.22 | 1.60% up | 23% up | ||
| 160 | CytokineticsCYTK · Health Care | -NOK 7.7B | NOK 69.8B | NOK 501.42 | 0.12% up | 19% down | ||
| 161 | TeleflexTFX · Health Care | -NOK 8.8B | NOK 63.3B | NOK 1,595.25 | 1.44% down | 58% up | ||
| 162 | Takeda PharmaceuticalTAK · Health Care | -NOK 9.3B | NOK 664.1B | NOK 207.87 | 0.14% up | 51% up | ||
| 163 | Baxter InternationalBAX · Health Care | -NOK 9.3B | NOK 128B | NOK 247.49 | 3.06% down | 50% up | ||
| 164 | Summit TherapeuticsSMMT · Health Care | -NOK 10.5B | NOK 82.2B | NOK 102.81 | 0.33% up | 36% down | ||
| 165 | Revolution MedicinesRVMD · Health Care | -NOK 11B | NOK 344.5B | NOK 1,592.81 | 2.12% up | 129% up | ||
| 166 | BioNTechBNTX · Health Care | -NOK 12.3B | NOK 199.2B | NOK 803.31 | 1.13% down | 14% down | ||
| 167 | InsmedINSM · Health Care | -NOK 12.5B | NOK 306.4B | NOK 1,396.61 | 19.46% up | 40% down | ||
| 168 | ModernaMRNA · Health Care | -NOK 27.5B | NOK 784.2B | NOK 1,938.18 | 0.92% up | 780% up | ||
| 169 | ViatrisVTRS · Health Care | -NOK 34.3B | NOK 222B | NOK 193.67 | 2.14% down | 99% up | ||
| 170 | CenteneCNC · Health Care | -NOK 65.1B | NOK 314.3B | NOK 634.92 | 3.54% down | 94% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 9.7590 NOK).
Questions and answers
Which health care companies rank first by earnings?
Johnson & Johnson (NOK 261.6B), Eli Lilly (NOK 201.4B) and Merck & Co (NOK 178.1B) are the top three of the 170 health care companies ranked by earnings as of 19 Nov 2026, 16:24 UTC.
How many health care companies are in this ranking?
170 are ranked by earnings.
What are these health care companies worth together?
The 170 health care companies ranked by earnings have a combined market value of NOK 87.2T as of 19 Nov 2026, 16:24 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest health care companies by earnings”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.